Back to Speakers
Assaf Barnea is the CEO of Sanara Ventures, a venture capital firm focused on investing in early-stage companies in the healthcare and life sciences sectors. He has over 20 years of experience in the venture capital and private equity industries, having held senior positions at leading venture capital firms such as Apax Partners, Pitango Venture Capital, and OrbiMed.
Assaf has a deep understanding of the healthcare and life sciences sectors, having invested in over 50 companies in the space. He has also served on the boards of numerous companies, including Teva Pharmaceuticals, Compugen, and BioCancell.
Assaf holds a B.A. in Economics and an M.B.A. from Tel Aviv University. He is a frequent speaker at industry events and a mentor to many entrepreneurs.
3 minutes Read
The financial industry is facing new challenges with the rise of ultra-high speed AI trading, blockchain technologies, and unconventional financial services platforms. This is causing blue chip banks to make significant investments in fintech. But what are the most promising technologies that the industry should be aware of? What regulatory shifts do investors need to prepare for? To what extent is the boom in the NFT market and the emergence of the Central Bank Digital Currency sustainable and indicative of long-term asset shifts?
3 minutes Read
AI is already accelerating science and health solutions, predicting protein folds critical to programming DNA and speeding up medical imagery analysis to detect disease. Health systems are ripe for a rethink driven by digitalization, new tools, and new disease prevention and treatment approaches. What are the most promising technologies and viable investment opportunities in the sector?
Get the latest investment news and insights delivered straight to your inbox.
